ENDRA Life Sciences Income Statement (2016-2025) | NDRA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)
Cost of Revenue (Quarter)	0.16M	0.26M	0.28M	0.38M	0.34M	0.34M	0.42M	0.33M	0.18M	0.25M	0.24M	0.15M	0.24M	0.16M	0.08M	0.09M	0.07M	0.07M	0.05M	0.01M
Gross Profit (Quarter)
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	1.14M	1.74M	1.17M	1.42M	1.21M	1.85M	1.83M	1.66M	1.39M	1.40M	1.63M	0.58M	1.04M	0.72M	0.79M	0.64M	0.53M	0.38M	0.43M	0.51M
Selling, General & Administrative (Quarter)	1.27M	1.20M	1.20M	1.27M	1.30M	1.38M	1.17M	1.32M	1.37M	1.35M	1.25M	0.73M	1.50M	1.35M	0.63M	3.57M	0.87M	0.85M	0.89M	1.11M
Other Operating Expenses (Quarter)	0.16M	0.26M	0.28M	0.38M	0.34M	0.34M	0.42M	0.33M	0.18M	0.25M	0.24M	0.15M	0.24M	0.16M	0.08M	0.09M	0.07M	0.07M	0.05M	0.01M
Operating Expenses (Quarter)	2.58M	3.20M	2.65M	3.07M	2.86M	3.57M	3.42M	3.31M	2.94M	2.99M	3.13M	1.46M	2.78M	2.23M	1.51M	4.30M	1.47M	1.30M	1.37M	1.62M
Operating Income (Quarter)	-2.58M	-3.20M	-2.65M	-3.07M	-2.86M	-3.57M	-3.42M	-3.31M	-2.94M	-2.99M	-3.13M	-1.46M	-2.78M	-2.23M	-1.51M	-4.30M	-1.47M	-1.30M	-1.37M	-1.62M
EBIT (Quarter)	-2.58M	-3.20M	-2.65M	-3.07M	-2.86M	-3.57M	-3.42M	-3.31M	-2.94M	-2.99M	-3.13M	-1.46M	-2.78M	-2.23M	-1.51M	-4.30M	-1.47M	-1.30M	-1.37M	-1.62M
Non-operating items
Other Non Operating Income (Quarter)	0.31M		-0.01M	-0.35M			-0.02M	0.02M	0.00M	0.44M	-0.03M	0.92M	0.00M	0.00M	3.07M	0.01M	0.02M	0.01M	0.04M
Non Operating Income (Quarter)	0.31M	0.00M	-0.01M	-0.34M	-0.00M	-0.02M	-0.02M	0.05M	0.00M	0.44M	-0.03M	0.92M	0.00M	0.00M	-0.85M	0.15M	0.02M	0.01M	0.04M	-1.55M
Net income details
EBT (Quarter)	-2.27M	-3.20M	-2.66M	-3.10M	-2.86M	-3.59M	-3.44M	-3.29M	-2.94M	-2.56M	-3.10M	-1.46M	-2.78M	-2.23M	-2.35M	-4.15M	-1.04M	-1.23M	-1.60M	-3.17M
Profit After Tax (Quarter)	-2.27M	-3.20M	-2.66M	-3.10M	-2.86M	-3.59M	-3.44M	-3.29M	-2.94M	-2.56M	-3.10M	-1.46M	-2.78M	-2.23M	-2.35M	-4.15M	-1.04M	-1.23M	-1.60M	-3.17M
Income from Continuing Operations (Quarter)	-2.27M	-3.20M	-2.66M	-3.10M	-2.86M	-3.59M	-3.44M	-3.29M	-2.94M	-2.56M	-3.10M	-1.46M	-2.78M	-2.23M	-2.35M	-4.15M	-1.04M	-1.23M	-1.60M	-3.17M
Consolidated Net Income (Quarter)	-2.27M	-3.20M	-2.66M	-3.10M	-2.86M	-3.59M	-3.44M	-3.29M	-2.94M	-2.56M	-3.10M	-1.46M	-2.78M	-2.23M	-2.35M	-4.15M	-1.04M	-1.23M	-1.60M	-3.17M
Income towards Parent Company (Quarter)	-2.27M	-3.20M	-2.66M	-3.10M	-2.86M	-3.59M	-3.44M	-3.29M	-2.94M	-2.56M	-3.10M	-1.46M	-2.78M	-2.23M	-2.35M	-4.15M	-1.04M	-1.23M	-1.60M	-3.17M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-2.39M	-3.20M	-2.66M	-3.10M	-2.86M	-3.59M	-3.44M	-3.29M	-2.94M	-2.56M	-3.10M	-1.46M	-2.78M	-2.23M	-2.35M	-4.15M	-1.04M	-1.23M	-1.60M	-3.17M
Additional items
EPS (Basic) (Quarter)	-0.06	-0.08	-0.06	-5.35	-0.07	-1.17	-1.23	-1.14	-0.93	-0.43	-963.59	-0.23	-449.58	-142.99	-9.54	25.20	-1.86	-6.78	-2.10	-3.25
EPS (Weighted Average and Diluted) (Quarter)												-401.41			-9.54	25.20			-2.10	-3.25
Shares Outstanding (Weighted Average) (Quarter)	37.77M	41.68M	40.47M	2.05M	2.15M	3.08M	2.80M	2.89M	3.17M	6.00M	0.00M	6.36M	0.01M	0.02M	0.25M	0.20M	0.56M	0.18M	0.18M	0.79M
Shares Outstanding (Diluted Average) (Quarter)												0.00M			0.09M	0.20M			0.76M	0.79M
EBITDA (Quarter)	-2.58M	-3.20M	-2.65M	-3.07M	-2.86M	-3.57M	-3.42M	-3.31M	-2.94M	-2.99M	-3.13M	-1.46M	-2.78M	-2.23M	-1.51M	-4.30M	-1.47M	-1.30M	-1.37M	-1.62M
Interest Expenses (Quarter)

Research Tools

ENDRA Life Sciences Income Statement (2016-2025) | NDRA

Create an account

Sign In

Reset Password